RhoA, Rac1 and Cdc42, the best-characterized members of the Rho family of small GTPases, are critical regulators of many cellular activities. Cdc42 GTPaseactivating protein (CdGAP) is a serine-and proline-rich RhoGAP protein showing GAP activity against both Cdc42 and Rac1 but not RhoA. CdGAP is phosphorylated downstream of the MEK-ERK (extracellular signalregulated kinase) pathway in response to serum and is required for normal cell spreading and polarized lamellipodia formation. In this study, we found that CdGAP protein and mRNA levels are highly increased in mammary tumor explants expressing an activated Neu/ ErbB-2 (Neu-NT) receptor. In response to transforming growth factor-b (TGFb) stimulation, Neu-NT-expressing mammary tumor explants demonstrate a clear induction in cell motility and invasion. We show that downregulation of CdGAP expression by small interfering RNA abrogates the ability of TGFb to induce cell motility and invasion of Neu-NT-expressing mammary tumor explants. However, it has no effect on TGFb-mediated cell adhesion on type 1 collagen and fibronectin. Interestingly, protein expression of E-Cadherin is highly increased in Neu-NT-expressing mammary tumor explants depleted of CdGAP. In addition, complete loss of E-Cadherin expression is not observed in CdGAP-depleted cells during TGFb-mediated epithelial to mesenchymal transition. Downregulation of the CdGAP expression also decreases cell proliferation of Neu-NT-expressing mammary tumor explants independently of TGFb. Rescue analysis using re-expression of various CdGAP deletion-mutant proteins revealed that the proline-rich domain (PRD) but not the GAP domain of CdGAP is essential to mediate TGFbinduced cell motility and invasion. Finally, we found that TGFb induces the expression and phosphorylation of CdGAP in mammary epithelial NMuMG cells. Taken together, these studies identify CdGAP as a novel molecular target in TGFb signaling and implicate CdGAP as an essential component in the synergistic interaction between TGFb and Neu/ErbB-2 signaling pathways in breast cancer cells.
Introduction
The development of metastatic breast tumors is the main cause of morbidity and mortality in breast cancer patients (Gupta et al., 1992; Jemal et al., 2008) . Gene amplification and overexpression of Neu/ErbB-2, a member of the epidermal growth factor receptor tyrosine kinase family, is found in 25-30% of primary breast cancer patients, who display a trend of early stage metastasis and poor survival rate (Slamon et al., 1987) . These clinical observations have been clearly supported by the establishment of several Neu/ErbB-2-dependent transgenic models of breast cancer, showing a causal relationship between overexpression of Neu/ErbB-2 and the development of metastatic breast tumors (Muller et al., 1988; Siegel et al., 1994; Ursini-Siegel et al., 2007) . In addition, it is becoming clear that Neu/ErbB-2-induced signaling pathways can be influenced by other signaling pathways leading to breast tumorigenesis. One good example of this is the transforming growth factorb (TGFb) pathway that functions with Neu/ErbB-2 to promote the metastatic process (Yang et al., 2002; Muraoka et al., 2003; Siegel et al., 2003; Wang et al., 2005; Muraoka-Cook et al., 2006; Northey et al., 2008) . However, it is not very clear how these two signaling pathways synergize to amplify the metastatic response.
The Rho subfamily of small GTPases, including RhoA, Cdc42 and Rac1, have important roles in the regulation of cell migration and invasion, cell polarity, vesicular trafficking, cell cycle progression, apoptosis and cancer (Titus et al., 2005; Bustelo et al., 2007; Karlsson et al., 2009; Tybulewicz and Henderson, 2009) . Rho proteins cycle between an active GTP-bound state and an inactive GDP-bound state. This cycle is regulated by three distinct families of proteins. Guanine nucleotide exchange factors catalyze the exchange of GDP for GTP, leading to activation in response to various stimuli (Cerione and Zheng, 1996) . GTPaseactivating proteins (GAP) increase the intrinsic GTPase activity, resulting in GTPase protein inactivation . Guanine nucleotide-dissociation inhibitors sequester and maintain inactive Rho GTPases in the cytoplasm (Van Aelst and D'Souza-Schorey, 1997) . Many lines of evidence now show that Rho GTPases are involved in cancer initiation and progression (Vega and Ridley, 2008) . However, unlike mutational activation of Ras that is observed in many human cancers, it appears that it is the expression of Rho proteins and their regulators that is altered in many cancer types (Go´mez del Pulgar et al., 2005) .
Cdc42 GTPase-activating protein (CdGAP) is a ubiquitous protein that regulates both Cdc42 and Rac1 activities, but not RhoA. CdGAP contains a N-terminal GAP domain, a basic central region and a proline-rich domain (PRD) with an extended C-terminal domain (Lamarche-Vane and Hall, 1998; Jenna et al., 2002; Tcherkezian et al., 2006) . We have previously shown that CdGAP is a substrate of ERK/GSK-3 and mediates cross talk between the Ras/MAP kinase pathway and regulation of Rac1 activity (Tcherkezian et al., 2005; Danek et al., 2007) . Furthermore, CdGAP is a serum-inducible gene (Danek et al., 2007) and is required for normal cell spreading, polarized lamellipodia and cell migration; important cellular processes involved in cancer progression (Lalonde et al., 2006) .
Here, we found increased levels of endogenous CdGAP in mammary tumor explant cells arising from NMuMG-immortalized mouse mammary cells expressing the activated Neu/ErbB-2 receptor compared with control cells (Northey et al., 2008) . These explant cells showed increased cell motility and invasion in response to TGFb (Northey et al., 2008) , and downregulation of CdGAP expression by short interfering RNA (siRNA) specifically inhibited in a GAP-independent manner the ability of TGFb to induce cell motility and invasion in these cells. Downregulation of CdGAP also decreased cell proliferation of NMuMG-activated Neu cells independently of TGFb. Thus, our findings show that CdGAP is specifically required for the mediation of TGFb effects on cell migration and invasion in breast cancer cells and additionally, regulates proliferation through a distinct pathway.
Results
The expression of CdGAP is increased in Neu-NT-expressing mammary tumor cells To investigate the role of CdGAP in breast cancer cells, we used an established Neu/ErbB-2-induced mammary tumor model (Northey et al., 2008) . As previously described, activated forms of the Neu/ErbB-2 receptor that either retains its phosphorylation sites within the cytoplasmic tail (Neu-NT) or contains tyrosine-tophenylalanine substitutions of five major phosphorylation sites (Neu-NYPD) were individually transfected into an immortalized mammary epithelial cell line (NMuMG), along with an empty vector control (Northey et al., 2008) . Pooled stable transfected cells were injected into the mammary fat pads of athymic mice. Neu-NTexpressing cells generated more rapidly growing mammary tumors that metastasized more aggressively to the lung compared with Neu-NYPD-expressing cells, whereas empty vector control cells failed to form tumors (Northey et al., 2008) . We examined the protein and mRNA expression levels of CdGAP in tumor cells explanted back into culture from two independent Neu-NT and Neu-NYPD mammary tumors compared with the empty vector control. Both Neu-NYPD and Neu-NT-expressing explants showed similar expression levels of Neu/ErbB-2 (Figure 1a) . Interestingly, we observed a modest but significant increase in CdGAP protein levels in Neu-NYPD-expressing cells and a higher increase in Neu-NT-expressing explants, when compared with empty vector control cells (Figures 1a  and b ). In particular, CdGAP protein levels showed a 12-and 20-fold increase in Neu-NT explants 118R and 118L, respectively, compared with the control explant ( Figure 1b) . To determine whether the increase in the levels of CdGAP protein resulted from a change in mRNA levels, we performed quantitative reverse transcription-PCR on vector control, Neu-NYPD and Neu-NT-expressing explants. As shown in Figure 1c , the mRNA levels of CdGAP were highly increased in Neu-NT and Neu-NYPD-expressing explants compared with the control empty explant. Given that the 118L Neu-NT tumor explant displayed the highest level of expression of CdGAP, we chose this explant for the following experiments.
Downregulation of CdGAP impairs the ability of TGFb to increase cell migration and invasion of Neu-NT-expressing mammary tumor explants To investigate whether CdGAP is involved in TGFbinduced cell migration and invasion of Neu-NT-expressing tumor explants, we downregulated the CdGAP expression by transfection using synthetic siRNA targeting CdGAP. By western blot analysis, we found that 90% of CdGAP expression was inhibited (Figures 2a and b) . After transfection with a scrambled control siRNA or CdGAP siRNA, Neu-NT-expressing cells were incubated in the absence or presence of TGFb for 24 h before plating the same number of cells on transwell filters in serum-free medium, allowing them to migrate towards fetal bovine serum in the bottom chamber for 24 h. As shown in Figure 2c , downregulation of CdGAP expression had no significant effect on cell migration in the absence of TGFb. As previously demonstrated (Northey et al., 2008) , TGFb induced the migration of Neu-NT-expressing cells transfected with control siRNA. However, loss of CdGAP significantly inhibited the ability of TGFb to stimulate cell migration (Figure 2c) . Similarly, using a matrigel assay, TGFb stimulation resulted in a twofold increase in invasion in control siRNA treated cells compared with unstimulated cells; whereas loss of CdGAP significantly blocked TGFb-induced invasion (Figure 2d ). Together, these results indicate that CdGAP is required for TGFb to mediate its effects on cell migration and invasion in Neu-NT-expressing cells.
Loss of CdGAP does not affect cell adhesion of Neu-NT-expressing cells Increased cell motility and invasion requires the dynamic assembly and disassembly of focal adhesions (Broussard et al., 2008) . Thus, we examined the effect of CdGAP depletion on cell adhesion of Neu-NT-expressing cells to extracellular matrix proteins; including type 1 collagen and fibronectin. We found that treatment of cells with TGFb before plating on type 1 collagen or fibronectin significantly increased cell adhesion of control and CdGAP-depleted cells (Figures 3a and b) . We also examined the effect of CdGAP on the formation of focal adhesion complexes. We determined the number of focal adhesion formed by immunofluor- 
Depletion of CdGAP induces E-Cadherin protein expression in Neu-NT-expressing cells
It has been well established that NMuMG cells undergo epithelial-to-mesenchymal transition (EMT) in response to TGFb (Miettinen et al., 1994; Bakin et al., 2000) . Moreover, increasing evidence suggests that this transition is associated with enhanced cell migration and invasion during tumor progression ( The PRD of CdGAP is essential for its function in TGFb-induced cell migration and invasion As shown in Figure 7a , CdGAP consists of a GAP domain at the N-terminus, a central basic region and a PRD with an extended C-terminus domain. To determine whether re-expression of CdGAP can rescue the migration and invasion defects in TGFb-treated cells, we co-transfected an expression vector encoding human CdGAP (hCdGAP) with siRNAs targeting specifically the C-terminus of mouse CdGAP (mCdGAP) in Neu-NT-expressing cells. The expression of hCdGAP was successfully achieved in the presence of CdGAP siRNA whereas endogenous CdGAP was reduced with CdGAP siRNA co-transfected with empty vector (compare lane 1 and 2, Figure 7b ). Interestingly, re-expression of hCdGAP was able to significantly rescue TGFb-increased cell migration and invasion of Neu-NT-expressing cells compared with control empty vector (Figures 7c, e and f). To characterize the regions of CdGAP required for TGFb-induced cell migration and invasion, we co-transfected various truncated CdGAP constructs lacking the C-terminus with CdGAP siRNA. CdGAP truncated proteins were expressed at a similar level of expression whereas endogenous CdGAP was significantly downregulated with CdGAP siRNA (Figures 7b and d) . Expression of hCdGAP (1-1087) was able to rescue TGFb-induced cell migration similar to expression of hCdGAP; however, hCdGAP (1-683) lacking the C-terminus and part of the PRD was unable to rescue cell migration and invasion induced by TGFb (Figures 7c and f) . Interestingly, expression of mCdGAP (1-820) or mCdGAP lacking the GAP domain rescued TGFb-induced cell migration and invasion, suggesting that the GAP domain is not required for CdGAP function in TGFb signaling (Figures 7e and f) . More importantly, CdGAP-PRD was sufficient to rescue TGFb-induced cell migration and invasion (Figures 7e  and f) . We have previously shown that CdGAP-PRD is highly phosphorylated on serine and threonine residues, and in particular, threonine-776 is an in vivo regulatory 
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Y He et al target site of ERK1/2 and GSK3 (Tcherkezian et al., 2005; Danek et al., 2007) . However, expression of the mutant protein mCdGAP-T776A was still able to rescue TGFb-induced cell migration, suggesting that this ERK/ GSK-3 phosphorylation site does not participate to those CdGAP functions that promote TGFb-induced cell migration (Figure 7e ). Altogether, these results suggest that a small region within the PRD of CdGAP is sufficient to mediate TGFb-induced cell migration and invasion in Neu-NT-expressing cells.
CdGAP is regulated by TGFb
To examine whether CdGAP is regulated in response to TGFb stimulation, we determined the mRNA and protein expression levels of CdGAP after TGFb stimulation of NMuMG control explant cells. The TGFb treatment of control explant cells for 24 h led to a significant increase in CdGAP mRNA and protein expression (Figures 8a-c) , whereas there was no effect in Neu-NT-and Neu-NYPD-expressing explant cells already expressing high levels of CdGAP (data not shown). Interestingly, when Neu-NT-expressing cells were treated with TGFb type I receptor inhibitor SB431542, a significant decrease in CdGAP mRNA and protein expression was observed (Figures 8d-f) , suggesting that CdGAP expression could be regulated by autocrine TGFb production in Neu-NT-expressing cells. Then, we examined the possibility that CdGAP phosphorylation could be induced by TGFb. Indeed, in vivo phosphorylation of CdGAP in control explant cells was transiently increased in response to TGFb stimulation, with a peak at 30 min, and decreased after 1-h stimulation, which synchronized with the phosphorylation pattern of Smad2/3 (Figure 8g ). CdGAPinduced phosphorylation by TGFb was abolished in the presence of SB431542 (Figure 8g ). These results show that CdGAP expression and phosphorylation are regulated by TGFb stimulation in mammary epithelial cells.
Discussion
In this study, we demonstrate that the phosphoprotein CdGAP is regulated by TGFb and has an important role in the synergy between TGFb and Neu/ErbB-2 signaling pathways in breast cancer cells. As previously demonstrated, TGFb treatment of breast tumor explants expressing a constitutively active form of Neu/ErbB-2 receptor tyrosine kinase (Neu-NT) enhanced cell motility and invasion (Northey et al., 2008) . The removal of five autophosphorylation sites in the cytoplasmic tail of Neu/ErbB-2 (Neu-NYPD) inhibited the synergistic effect of these two signaling pathways on cell migration and invasion. Here, we found that these highly motile Neu-NT-expressing cells showed a 10-20-fold increase in the levels of expression of CdGAP protein and mRNA. Neu-NYPD explant cells lacking the cooperation between TGFb and Neu/ ErbB-2 signaling pathways also demonstrated an increase in CdGAP expression compared with control explants but it was significantly lower than Neu-NT tumor explants. We demonstrate that reduction of CdGAP protein in Neu-NT tumor cells inhibited TGFb-induced cell migration and invasion. In the absence of TGFb, downregulation of CdGAP levels did not alter the migration or invasion capabilities of Neu-NT explant cells. Therefore, these findings reveal a key role for CdGAP in mediating the synergy between TGFb and Neu/ErbB-2 signaling pathways.
Neu-NT tumor explants formed fewer and smaller focal adhesions in response to TGFb compared with control cells or Neu-NYPD tumor explants (Northey et al., 2008) . In keeping with previous observations, we determined that Neu-NT tumor explants possessed on average 4-6 focal adhesions per cell and addition of TGFb did not significantly increase the number and size of focal adhesions per cell. When we examined the number of focal adhesions in Neu-NT explant cells depleted of CdGAP, we found no significant difference in the number and size of focal adhesions compared with control cells. Furthermore, adhesion of Neu-NT explant cells on type 1 collagen or fibronectin was not affected by the removal of CdGAP. Thus, CdGAP is required for TGFb-enhanced motility and invasion of Neu-NT tumor explants but is not essential for adhesion to extracellular matrix in this cellular context, even though CdGAP has been shown to localize to focal adhesions through its interaction with actopaxin in U2OS osteosarcoma cells (Lalonde et al., 2006) . Cell CdGAP regulates cell migration and invasion Y He et al migration is the result of coordinated regulation of cytoskeletal dynamics and the assembly and disassembly of focal adhesions (Carragher and Frame, 2004) . Therefore, we cannot exclude the possibility that CdGAP has a role in mediating focal adhesion dynamics that will need further investigation using live cell video microscopy to quantify focal adhesion turnover. Interestingly, depletion of CdGAP in Neu-NT explant cells led to a significant increase in E-Cadherin with a clear cell morphology change. Although TGFb-mediated EMT in these cells was accompanied by a fibroblastoid phenotype and a gain in fibronectin expression, a complete loss of E-Cadherin was not observed after two days of TGFb treatment compared with control cells. These findings suggest that removal of CdGAP may result in a failure to properly dismantle cell junctions, thus impairing TGFb-induced cell motility and invasion.
Several identified GAPs and guanine nucleotide exchange factors for Rho proteins have been implicated in cell migration and adhesion (Raftopoulou and Hall, 2004) . For instance, DLC1 (deleted in liver cancer), a GAP for Rho proteins, suppresses cell proliferation, migration and invasion in hepatocellular carcinoma cells. DLC1 is thought to serve as a tumor suppressor protein by antagonizing the oncogenic activity of Rho proteins in liver cancer (Wong et al., 2005; Xue et al., 2008) . In contrast, p190A RhoGAP-deficient fibroblasts showed a defect in polarized cell migration (Tomar et al., 2009 ) although they did not exhibit any obvious defects in adhesion on extracellular matrix (Jiang et al., 2008) . In both cases, the GAP activity of DLC1 and p190A was implicated in the regulation of cell migration. On the contrary, the mechanism by which CdGAP contributes to TGFb-mediated cell migration and invasion does not implicate its GAP domain, suggesting that modulation of Rac/Cdc42 GTPase activity is not essential for this effect. These results are in good agreement with Northey et al. (2008) , who did not observe any significant differences in Rho GTPase activity in Neu-NT-expressing cells that would explain the synergy in cell motility and invasion. In fact, CdGAP-PRD was sufficient to rescue the ability of TGFb to induce cell migration and invasion in Neu-NTexpressing cells. This domain of CdGAP interacts with the protein kinases ERK1/2, p90RSK-1, GSK3 and has been shown to be highly phosphorylated on serine and threonine residues (Tcherkezian et al., 2005; Danek et al., 2007) . Thr-776, a common phosphorylation site for both ERK1/2 and GSK-3, is an important negative regulatory site of CdGAP activity (Tcherkezian et al., 2005; Danek et al., 2007) . The mutant protein CdGAP-T776A, showing higher GAP activity towards Rac1 (Tcherkezian et al., 2005) , was still able to rescue TGFbmediated cell migration, suggesting that this ERK/ GSK-3 phosphorylation site does not contribute to CdGAP function in TGFb-induced cell migration.
Other phosphorylation sites that still remain to be identified in the PRD may be responsible for CdGAP function. Alternatively, the identification of novel binding partners with this region may help to delineate the mechanism by which the PRD contributes to CdGAP function in TGFb signaling.
In addition to its role in the synergistic interaction between TGFb and Neu/ErbB-2 signaling pathways in cell migration and invasion, we found that the CdGAP expression and phosphorylation were regulated by TGFb in mammary epithelial NMuMG cells. Indeed, treatment of NMuMG cells with TGFb led to an increase in both CdGAP protein and mRNA levels. Similarly, CdGAP expression was also found to be upregulated by serum in a GSK-3-dependent manner in NIH3T3 fibroblast cells (Danek et al., 2007) . In the canonical TGFb signaling pathway, ligand binding to the heterotrimeric receptor complex type I and II receptor kinases leads to transphosphorylation and activation of type I receptors by type II receptors, followed by Smad2/3 phosphorylation, which then form heteromeric complex with Smad4. Upon nuclear translocation, the protein complex activates or inhibits the expression of specific target genes (Derynck and Zhang, 2003; Pardali and ten Dijke, 2009 ). Here, we also found that phosphorylation of CdGAP was transiently increased in response to TGFb stimulation of NMuMG cells, following the same kinetic observed for TGFbinduced Smad2/3 phosphorylation. It will be of great interest to determine whether CdGAP is a direct phosphorylation substrate of type I/II receptors or is targeted by non-smad pathways activated by TGFb (Nagaraj and Datta, 2010) . Interestingly, a study using the automated high-throughput technology LUMIER (luminescence-based mammalian interactome mapping) to map protein-protein interaction networks in the TGFb signaling pathway in mammalian cells identified CdGAP as a protein interactor in the TGFb signaling network . This supports well our findings that implicate CdGAP as a novel molecular component within TGFb signaling pathways.
As negative regulators of Rho GTPases, GAPs are often seen as tumor suppressor proteins Kim et al., 2009) . Our findings indicating that CdGAP depletion reduces cell proliferation and that CdGAP is essential for TGFbmediated cell migration and invasion in a GAPindependent manner, raise the possibility that CdGAP may act as a positive modulator of breast cancer cell growth, motility and invasion. 
Materials and methods
Cell lines and DNA constructs All NMuMG-derived mammary tumor explant cells were generated and grown as previously described (Northey et al., 2008) . Mouse and hCdGAP constructs were as described previously (Southgate et al., submitted; Tcherkezian et al., 2005 Tcherkezian et al., , 2006 .
Immunoblotting and quantitative reverse transcription PCR Cells were lysed in buffer containing 20 mM Tris pH 7.4, 100 mM NaCl, 1% Triton X-100, 1 mM phenylmethylsulfonyl fluoride, 1 mM EDTA, 50 mM NaF, 1 mM sodium orthovanadate and protease inhibitors. Protein lysates were subjected to 7.5% SDS-PAGE and transferred to nitrocellulose. The membranes were incubated with polyclonal anti-CdGAP antibodies (Danek et al., 2007) , Neu/ErbB-2 (Santa Cruz), Smad2/3 (Cell Signaling, Danvers, MA, USA), phosphoSmad2/3 (Ser465/467) (Cell Signaling), E-Cadherin (Sigma, St Louis, MO, USA), Fibronectin (Sigma), b-tubulin (Sigma) or b-actin (Sigma) followed by incubation with horseradish peroxidase-conjugated anti-IgG secondary antibodies for 1 h and visualized by enhanced chemiluminescence (PerkinElmer). Quantitative reverse transcription PCR was performed as previously described (Danek et al., 2007) .
siRNA knockdown and transient transfections Neu-NT-expressing mammary tumor explant cells were transfected using Lipofectamine 2000. For siRNA transfection experiments, Neu-NT-expressing explant cells were transfected with CdGAP targeting siRNA duplex (5 0 -GGGACCAUCUG GUAUACAAtt-3 0 ) (Applied Biosystems, Carlsbad, CA, USA) or a scrambled control siRNA duplex. The final concentration of siRNA was 30 nM per transfection. Explant cells were transfected three times as previously described (Northey et al., 2008) . At 6h after the last transfection, Neu-NT-expressing mammary tumor explant cells were incubated in complete medium overnight. Then, cells were treated with 5 ng/ml TGFb (Invitrogen, Carlsbad, CA, USA) for 24 h and subjected to migration, invasion or adhesion assays. For motility and invasion rescue experiments, 8 mg plasmid/60 mm dish of pRK5myc-hCdGAP, -hCdGAP (1-1087),-hCdGAP (1-683), mCdGAP (1-820), -mCdGAP-DGAP, -mCdGAP-PRD, -mCdGAP-T776A and pRK5myc empty vector were used.
Cell migration and invasion assays
For migration assays, 50 000 cells pre-treated with or without TGFb for 24 h, were resuspended in serum-free medium and plated in the top chamber of transwell inserts (Falcon, San Jose, CA, USA). For invasion assays, 150 000 cells were plated onto a 5% matrigel layered over the top chamber. Cells were allowed to migrate toward medium with 10% fetal bovine serum in the bottom chamber. After 24 h, cells on the bottom surface of the insert were fixed in 10% formalin and stained with a crystal violet solution. Five images were taken for each transwell insert using an Axiovert 135 Zeiss ( Â 10 magnification, A-plan) objective lens. Data are representative of the average pixel count of each image that was quantitated using Scion Image software (Scion Corporation, Frederick, MD, USA). Four independent inserts were quantified for each explant, in the absence or presence of TGFb.
Cell adhesion assay 40 000 cells pre-treated with or without TGFb for 24 h were resuspended in serum-free medium containing 0.5% bovine serum albumin and seeded on type 1 collagen (BD Bioscience, San Jose, CA, USA) or fibronectin (Sigma) coated 96-well plate for 30 min at 37 1C. Cells were fixed and stained with a crystal violet solution. After the excess dye was washed out and being dried, the crystal violet absorbed by the cell nuclei was extracted with 10% acetic acid. The optical density at 590 nm was measured for each well.
Immunofluorescence Cells were fixed for 10 min with 3.7% formaldehyde in PBS. Fixed cell were permeabilized for 5 min in 0.25% Triton X-100. After 30 min blocking with 0.5% bovine serum albumin in PBS, cells were stained with anti-FAK (Upstate) or antivinculin (Sigma) antibodies for 45 min, followed by incubation with a secondary Alex Fluor 555-conjugated anti-rabbit and Alex Fluor 488-phalloidin (Molecular Probes, Carlsbad, CA, USA) to stain for actin filaments. Nuclei were stained with 4 0 ,6 0 -diamidino-2-phenylindole. Coverslips were examined on a Zeiss Axiovert 135 microscope using Zeiss oil immersion Â 40 objective lens. Images were taken using Retiga Exi non-cooled 12-bit digital CCD camera and analyzed using the Northern Eclipse software (Empix imaging, Mississauga, ON, Canada). The average number of focal adhesions was quantified as previously described (Northey et al., 2008) . Focal adhesions were distinguished by employing a fixed range of fluorescence intensity and a size 41 mm 2 across all images. The data Cell proliferation assay MTT assays were performed using the cell growth determination kit MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide)-based kit (Sigma). Briefly, 800 cells transfected with CdGAP siRNA or scrambled control siRNA were seeded onto 96-well plate. After serum starvation for 24 h, cells were treated with or without TGFb in complete medium for 24 h. MTT solution was added to each well for the last 4 h of treatment. The reaction was stopped with the addition of MTT solvent reagent. Optical density was determined at 570 nm using a multiwell plate reader.
In vivo (32P) orthophosphate labeling NMuMG empty control explant cells were serum-starved for 20 h. Then, cells were incubated in phosphate-free medium for 1 h before labeling and incubated for 3 h in the presence of 0.5 mCi of (32P) orthophosphate per ml. Cells were treated with the TGFb type I receptor inhibitor SB431542 (Tocris Bioscience, Ellisville, MO, USA) or with 0.1% ethanol as a control for 1 h before TGFb stimulation. The cells were then stimulated with TGFb for 30 or 60 min or were left unstimulated. Endogenous CdGAP was immunoprecipitated from cell lysates using polyclonal anti-CdGAP antibodies overnight at 4 1C, and proteins were separated by SDS-PAGE, followed by transfer to nitrocellulose and then autoradiography and immunoblotting for CdGAP.
Statistical analysis
Statistical significance value (P-values) was obtained by performing a two-sample unequal-variance Student's t-test. Data are representative of at least three independent experiments.
